share_log

BRIEF-Living Cell Technologies Secures Funding For Third Clinical Trial Of NTCELL In Parkinson's Disease

reuters ·  Oct 18, 2021 20:56

Oct 19 (Reuters) - Living Cell Technologies Ltd LCT.AX :

* SECURED FUNDING FOR A THIRD CLINICAL TRIAL OF NTCELL IN PARKINSON'S DISEASE

* COMPLETED PLACEMENT RAISING A$3.5 MILLION

Source text for Eikon: ID:nASXbgXbmM Further company coverage: LCT.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment